These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 28746790)

  • 1. Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway.
    Zhang J; Li Z; Liu L; Wang Q; Li S; Chen D; Hu Z; Yu T; Ding J; Li J; Yao M; Huang S; Zhao Y; He X
    Hepatology; 2018 Jan; 67(1):171-187. PubMed ID: 28746790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Non-Coding RNAs (lncRNAs) Tumor-Suppressive Role of lncRNA on Chromosome 8p12 (TSLNC8) Inhibits Tumor Metastasis and Promotes Apoptosis by Regulating Interleukin 6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Hypoxia-Inducible Factor 1-alpha (HIF-1α) Signaling Pathway in Non-Small Cell Lung Cancer.
    Fan H; Li J; Wang J; Hu Z
    Med Sci Monit; 2019 Oct; 25():7624-7633. PubMed ID: 31601776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical functions of long noncoding RNAs in modulating STAT3 signaling pathway in hepatocellular carcinoma.
    Mohan CD; Rangappa S; Nayak SC; Sethi G; Rangappa KS
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188574. PubMed ID: 34062154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
    Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
    Tang C; Feng W; Bao Y; Du H
    Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-26a suppresses tumor growth and metastasis of human hepatocellular carcinoma by targeting interleukin-6-Stat3 pathway.
    Yang X; Liang L; Zhang XF; Jia HL; Qin Y; Zhu XC; Gao XM; Qiao P; Zheng Y; Sheng YY; Wei JW; Zhou HJ; Ren N; Ye QH; Dong QZ; Qin LX
    Hepatology; 2013 Jul; 58(1):158-70. PubMed ID: 23389848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway.
    Yin YZ; Zheng WH; Zhang X; Chen YH; Tuo YH
    J Cell Biochem; 2020 Jan; 121(1):735-742. PubMed ID: 31478228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 8p tumor suppressor genes SH2D4A and SORBS3 cooperate to inhibit interleukin-6 signaling in hepatocellular carcinoma.
    Ploeger C; Waldburger N; Fraas A; Goeppert B; Pusch S; Breuhahn K; Wang XW; Schirmacher P; Roessler S
    Hepatology; 2016 Sep; 64(3):828-42. PubMed ID: 27311882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
    Zhao H; Guo Y; Li S; Han R; Ying J; Zhu H; Wang Y; Yin L; Han Y; Sun L; Wang Z; Lin Q; Bi X; Jiao Y; Jia H; Zhao J; Huang Z; Li Z; Zhou J; Song W; Meng K; Cai J
    Oncotarget; 2015 Oct; 6(31):31927-43. PubMed ID: 26376676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma.
    Wang H; Liang L; Dong Q; Huan L; He J; Li B; Yang C; Jin H; Wei L; Yu C; Zhao F; Li J; Yao M; Qin W; Qin L; He X
    Theranostics; 2018; 8(10):2814-2829. PubMed ID: 29774077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
    Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
    J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway.
    Zhou SZ; Li H; Wang ZW; Wang MH; Li N; Wang YF
    Cell Cycle; 2020 Nov; 19(21):2776-2792. PubMed ID: 33064977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
    Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic value of HER-2/neu, STAT3 and SOCS3 in hepatocellular carcinoma.
    Jiang LH; Hao YL; Zhu JW
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):282-291. PubMed ID: 30385249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
    Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CKLF1 Enhances Inflammation-Mediated Carcinogenesis and Prevents Doxorubicin-Induced Apoptosis via IL6/STAT3 Signaling in HCC.
    Liu Y; Liu L; Zhou Y; Zhou P; Yan Q; Chen X; Ding S; Zhu F
    Clin Cancer Res; 2019 Jul; 25(13):4141-4154. PubMed ID: 30918019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.
    Mano Y; Aishima S; Fujita N; Tanaka Y; Kubo Y; Motomura T; Taketomi A; Shirabe K; Maehara Y; Oda Y
    Pathobiology; 2013; 80(3):146-54. PubMed ID: 23364389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
    Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.